Details

Autor(en) / Beteiligte

• Appleby, Sarah
• Aitken-Buck, Hamish M.
• Holdaway, Mark S.
• Byers, Mathew S.
• Frampton, Chris M.
• Paton, Louise N.
• Richards, A. Mark
• Lamberts, Regis R.
• Pemberton, Christopher J.

Titel

Cardiac effects of myoregulin in ischemia-reperfusion

Ist Teil von

• Peptides (New York, N.Y. : 1980), 2024-04, Vol.174, p.171156-171156, Article 171156

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2024

Quelle

MEDLINE

Beschreibungen/Notizen

• Myoregulin is a recently discovered micropeptide that controls calcium levels by inhibiting the intracellular calcium pump sarco-endoplasmic reticulum Ca2+-ATPase (SERCA). Keeping calcium levels balanced in the heart is essential for normal heart functioning, thus myoregulin has the potential to be a crucial regulator of cardiac muscle performance by reducing the rate of intracellular Ca2+ uptake. We provide the first report of myoregulin mRNA expression in human heart tissue, absence of expression in human plasma, and the effects of myoregulin on cardiac hemodynamics in an ex vivo Langendorff isolated rat heart model of ischemia/reperfusion. In this preliminary study, myoregulin provided a cardio-protective effect, as assessed by preservation of left ventricular contractility and relaxation, during ischemia/reperfusion. This study provides the foundation for future research in this area. •Myoregulin mRNA is expressed in human heart tissue.•Myoregulin only influenced heart function during ischaemia/reperfusion injury.•Myoregulin had a protective effect on left ventricular contractility and relaxation.